A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...

The Food and Drug Administration recently approved a new drug for those living with advanced Parkinson’s. Movement disorders neurologist Dr. Leon Meytin with Hartford HealthCare’s Ayer ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...

Jan. 3, 2025 — Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug ... 'Dancing the Blues Away' Seen in Brain ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

Delray Medical Center cut the ribbon on its newest high-tech machine that targets brain areas to treat movement disorders such as essential tremor and tremor-dominant Parkinson’s disease.

The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...

New research reveals a significant reduction in Parkinson’s disease risk among autoimmune patients treated with anti-TNF or ...

University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson's disease patients ... loss of dopamine, a drug called levodopa is ...

2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new ... Researchers Develop Analytical Pipeline to Identify ...